China Feihe Limited

China Feihe Limited

CHFLF
China Feihe LimitedUS flagOther OTC
0.35
USD
- -
- -
3.08BMarket Cap
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
Revenue per Share
0.42
0.66
1.16
1.68
2.08
2.55
2.38
2.16
2.29
2.01
Basic EPS, GAAP
0.05
0.13
0.25
0.48
0.83
0.77
0.55
0.37
0.39
0.21
Free Cash Flow per Basic Share
- -
0.19
0.2
0.44
0.78
0.6
0.53
0.38
0.38
0.15
Dividend per Share
- -
- -
- -
0.33
0.3
0.38
0.24
0.28
0.29
0.25
Book Value per Share
- -
- -
0.53
0.72
1.18
1.56
1.87
1.93
2.07
2.05
Tangible Book Value per Share
0.26
0.4
0.64
1.59
2.14
2.5
2.83
2.89
3.01
2.88
Basic Weighted Avg Shares
8,933
8,933
8,933
8,157
8,933
8,923
8,941
9,060
9,049
9,025
Sales/Revenue/Turnover
3,724
5,887
10,392
13,722
18,592
22,776
21,311
19,532
20,749
18,113
Operating Margin (%)
19.22
26.28
30.69
40.62
43.38
41.66
31.77
26.45
26.83
19.29
Depreciation Expense
99
98
162
181
263
443
494
608
649
514
Net Income, GAAP
417
1,160
2,242
3,935
7,437
6,871
4,942
3,390
3,570
1,939
Effective Tax Rate (%)
31.73
29.73
29.68
30.76
24.89
28.51
25.74
32.16
34.16
37.54
Profit Margin (%)
11.2
19.71
21.58
28.67
40
30.17
23.19
17.36
17.21
10.71
Working Capital
975
1,333
2,434
9,850
11,437
13,028
14,770
15,172
15,658
13,508
LT Debt
- -
64
792
1,845
871
737
988
1,044
539
250
Total Equity
2,377
3,585
5,787
13,030
19,186
22,403
25,475
26,334
27,407
26,121
Return on Invested Capital (%)
- -
27.43
34.48
28.84
30.18
29.43
19.33
12.58
12.83
7.76
Return on Capital (%)
- -
156.59
59.82
45.38
61.6
45.86
27.44
17.54
16.8
8.53
Return on Common Equity (%)
- -
116,022,600
94.76
74
90.59
56.29
32.33
19.84
19.69
10.42

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
6.65%
-4.69%
Free Cash Flow
- -
-24.58%
-61.33%
Net Income, GAAP
- -
-21.49%
-45.68%
Sales/Revenue/Turnover
- -
0.25%
-12.7%
Total Cash Common Dividend
- -
-0.56%
-13.58%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
19,532
2024
- -
- -
- -
- -
20,749
2025
- -
- -
- -
- -
18,113

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
0.37
2024
- -
- -
- -
- -
0.39
2025
- -
- -
- -
- -
0.21

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
0.28
2024
- -
- -
- -
- -
0.29
2025
- -
- -
- -
- -
0.25

Company Description

APIChatGPT
CEO
Youbin Leng
Full Time Employees
9,590
Sector
Consumer Defensive
Industry
Packaged Foods
Address
Star City International Building Beijing People's Republic of China 100016
IPO Date
Mar 4, 2022
Website
feihe.com
Business
China Feihe Limited (Ticker: CHFLF) is a leading producer of infant formula milk powder and other dairy products in China, specializing in premium formula made from proprietary Feihe milk sources. The company offers a comprehensive portfolio of products including infant and young child formula milk powders under the Feihe brand, such as Feiyi, Feiqiong, and Feihong series; adult milk powders; liquid milk products; and goat milk formulas, all emphasizing high-quality, traceable domestic milk from its integrated supply chain in Heilongjiang province. Feihe operates primarily in the consumer staples sector, targeting mothers, families, and health-conscious adults across China with a focus on nutritional dairy solutions backed by scientific research and innovation. Founded in 1962 and headquartered in Beijing, China, the company maintains extensive geographic operations within China, including manufacturing facilities, dairy farms, and distribution networks spanning key regions. Feihe sources fresh milk exclusively from its own pastures and partner farms in northern China, ensuring product purity and compliance with stringent safety standards. It serves as a standalone listed entity on the Hong Kong Stock Exchange since 2015, with no major parent company relationships noted. In recent developments, China Feihe expanded its product offerings with new launches including upgraded organic infant formulas and advanced nutritional supplements in 2024, responding to evolving consumer demands for immunity-boosting and cognitive health products. The company secured strategic partnerships with leading pediatric research institutions for clinical validations and invested in supply chain enhancements, including new high-tech dairy farms to boost production capacity amid rising domestic demand. Additionally, Feihe announced a significant share repurchase program in late 2024 and reported robust revenue growth in its 2025 interim results, driven by market share gains in the premium infant formula segment.

Company News

APIChatGPT
  • The 3 Most Undervalued Stocks Under $1 to Buy Now: August 2023